New Mountain Capital buys health benefits administrator HealthComp from Alpine Investors
Private equity major New Mountain Capital has bought healthcare benefits administrator HealthComp from Alpine Investors.
Private equity major New Mountain Capital has bought healthcare benefits administrator HealthComp from Alpine Investors.
Human API, which is helping consumers to connect and share electronic health data with companies, has bagged $20m in its Series C.
GHO Capital and some of its LPs have secured the majority stake in Envision Pharma previously held by Ardian.
German resilience is helping the DACH region power towards its highest annual private equity deal value total for a decade despite the bruising impact of the coronavirus pandemic on firms across the globe.
While advisers readied themselves for a wave of distressed opportunities off the back of the coronavirus crisis – and GPs anticipated a shift in LP allocation strategies – the turnarounds surge has failed to materialise.
NEW YORK--(BUSINESS WIRE)-- Global investment firm KKR today announced the signing of agreements with NextEra Energy Resources, LLC, a subsidiary of NextEra Energy, Inc. (NYSE: NEE), and NextEra Energy Partners, LP (NYSE: NEP) relating to
From: FinTech Global FinTech Sidetrade has teamed up with merchant bank Hyman Capital help private equity clients adjust to Covid-19. The deal will see Sidtrade help the investment firm to assist its clients and private
While the search for the next chief investment officer for California Public Employees’ Retirement System (CalPERS) is still ongoing, it’s clear that the US’ largest public pension fund wants more investment into private equity. In
More than two-thirds of British pension funds are set to increase their investments into renewables, according to a new survey by Pureprofile and Alpha Real Capital. Having polled 50 pension fund investors, the researchers found
Global venture capital investment remains strong despite dealmaking numbers dropping for the sixth consecutive quarter, new research shows, with a trio of $1bn-plus deals from across the globe helping buoy the industry's figures.
High-Tech Gründerfonds (HTGF) and Bayern Kapital have sold their stakes in Germany-based nanobodies development company ChromoTek to US-based antibody developer Proteintech.
Asian asset manager Keppel Capital has hit a first close for its $1bn-targeting real estate fund Alpha Asia Macro Trends Fund IV.
